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Induction ofornithine decarboxylase has been correlated with theonset ofcellular proliferation
and cAMP production. Whether the resulting increases in polyamine levels are essential
mediators of growth and/or differentiation or are merely incidental remains controversial. We
have used FRTL-5 thyroid cells in culture to study the effects of three growth factors on ornithine
decarboxylase activity. These factors [TSH, bovine calf serum, and 12-0-tetradecanoylphorbol-
13-acetate (TPA)] are thought to act through different intracellular pathways. TSH stimulates
cAMP production in thyroid cells, calf serum acts through ill-defined pathways to stimulate
growth, and TPA is known to activate protein kinase C.
Bovine calf serum and TSH acted synergistically to induce ornithine decarboxylase activity.
Activity was maximal when the phosphodiesterase inhibitor, methyl isobutyl xanthine, was
included. Individually, neither serum nor TSH was a potent stimulator of the enzyme. Ornithine
decarboxylase mRNA was apparent on Northern blots as a doublet following one hour of
exposure to these agents. TPA did not stimulate ornithine decarboxylase activity and had an
inhibitory effect on enzyme induction by TSH and serum. Difluoromethylornithine, a specific
inhibitor of ornithine decarboxylase, inhibited growth induced by both TPA and TSH in
putrescine-free medium. This effect was not apparent in medium containing 10-'M putrescine.
The data indicate that, although intracellular levels ofcyclic AMP regulate ornithine decarbox-
ylase activity, a component in serum is necessary for significant induction ofthis enzyme. Factors
stimulating growth by non-cyclic AMP-dependent pathways may act without apparently
stimulating this enzyme, although polyamines appear to be essential for their growth stimulatory
effects.
INTRODUCTION
Ornithine decarboxylase (EC 4.1.1.17; L-ornithine carboxy-lyase; ODC) is the first
and rate-limiting enzyme in the polyamine biosynthetic pathway [1,2]. Increases in
enzyme activity and intracellular polyamine levels have been linked with cell growth
and tumor promotion [2]. Various cAMP analogs, phosphodiesterase inhibitors, and
hormones known to activate adenylate cyclase have also been shown to induce ODC in
several cells and tissues [3], including the thyroid [4]. Whether elevated cAMP levels
mediate trophic stimulation of ODC activity [5,6] depends on the tissue studied.
Growth in an adrenocortical tumor cell line (Y1) is inhibited both by ACTH and 8
BrcAMP, yet both agents stimulate ODC activity [7]. Growth occurs in the presence
of elevated levels of cAMP in a rat thyroid cell line (FRTL-5) [8], but the effects of
cANMP and growth factors on ornithine decarboxylase activity have not been studied.
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The phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), a known tumor
promoter, has been shown to cause increased ODC activity in a wide range ofcells and
tissues such as Chinese hamster ovary (CHO) cells [9,10] and mouse epidermal cell
cultures [11]. Enzyme induction is postulated to proceed by a mechanism independent
of cAMP-dependent kinase [9,10]. In thyroid cells we have shown that TPA exerts
effects antagonistic to those mediated by elevations in cAMP [12].
In this present study, we examined three growth stimulators for their ability to
induce ornithine decarboxylase activity in a cloned, normal line of TSH-dependent,
functional rat thyroid cells (FRTL-5) [8,13]. In FRTL-5 cells, growth is dependent on
the presence of insulin, thyroid stimulating hormone (TSH), and elevations in cAMP
and bovine calf serum [8,14-16]. By themselves, none of these factors stimulates
growth to any appreciable extent, but together there is synergy. The tumor promoter
TPA also stimulates growth in this cell line but via a mechanism independent ofcyclic
AMP [12]. By using growth factors which act through discrete intracellular pathways,
we hoped to define the role ofornithine decarboxylase induction in thyroid growth and
function.
MATERIALS
Hormones and chemicals were purchased from the Sigma Chemical Corporation,
St. Louis, MO. Media for cell culture were purchased from Gibco, Grand Island, NY.
Difluoromethylornithine (DFMO) was kindly supplied by the Merrell Dow Research
Institute, Cincinnati, OH. Omnifluor was supplied by New England Nuclear, and
NCS tissue solubilizer came from Amersham. Mouse ornithine decarboxylase cDNA




FRTL-5 cells were a generous gift from Dr. L. Kohn (N.I.H.) and the Interthyr
Foundation and were cultured asdescribed by Valente et al. [8] with the exception that
the TSH concentration was maintained at 1 mU/ml. Cells are dependent on TSH for
growth, and in its absence little or no growth is seen [8,14,15]. Cells were cultured for
five days without TSH in 5 percent bovine calf serum and the five supplements
described by Valente et al. [8], i.e., 10,g/ml insulin, 10-8M cortisol, 5 ,g/mL
transferrin, 10 ng/mL glycyl-L-histidyl-L-lysine acetate, and 10 ng/mL somatostatin.
These five supplements are referred to as "5H" in articles describing these cells [8,13]
and in the experiments presented in this paper. In all experiments presented, 5H was
included in the medium. The combination of 5H with TSH is known as 6H.
ODCAssay
Cells were scraped from 9.6 cm2 wells in 500 4L of ODC assay buffer [50 mM Tris
HCI, 1 mM EDTA, 15 mM dithiothreitol (DTT) (pH 7.8)] and sonicated for 12
five-second periods on a Branson sonicator, speed 1. The homogenate was centrifuged
at 27,000 g for 30 minutes. ODC activity was determined in 100 ,uL of supernatant,
using the procedure of Kudlow et al. [7]. Assay mixture (200 AL) contained 50 mM
Tris HCI (pH 7.8), 1.0 mM EDTA, 0.1 mM pyridoxal phosphate, 15 mM DTT, 0.4
mM L-ornithine, and 0.4IACi ofDL-['4C]-ornithine with specificity activity 56 mCi/m
mol, purchased from Amersham (Amersham Co., Arlington Heights, IL). On receipt,
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isotope was mixed with an equal volume of0.1 M HCl and evaporated to dryness on a
rotary evaporator; this procedure removes a volatile contaminant [4] which gives high
backgrounds in the ODC assays. The isotope was suspended in the original volume in
0.01 M HCl.
/Methyl-3HIThymidine Incorporation Assay
Cells were incubated in medium containing the five supplements, 5 percent calf
serum, and I ,uCi/well [methyl-3H]thymidine, specific activity 40-60 Ci/m mol
(Amersham), and the supplements as noted for 48 hours. Experimental details for
individual experiments are given in the figure legends. Experiments were terminated
by removing the medium and washing the cell layer with ice-cold Hank's balanced salt
solution. Cells were removed from the wells with 200 ,uL 0.1 M NaOH and transferred
to centrifuge tubes. Wells were rinsed twice with 200 ,uL 0.1 M NaOH and washings
were transferred to the tubes. The solubilized cells were incubated with 2.5 mL 6
percent trichloracetic acid for 20 minutes at 40C. Tubes werecentrifuged at 2,000gfor
ten minutes in the cold. The precipitates remaining after aspiration ofthe supernatant
were washed with 2 mL 6 percent trichloracetic acid and centrifuged again. Precipi-
tates were dissolved in 400 AL NCS solubilizer and counted in 10 mL scintillation fluid
containing 0.4 percent Omnifluor in toluene. Samples were counted in a Searle Mark
III liquid scintillation counter with a dpm accessory.
DNA was also measured, using a diphenylamine colorimetric assay as described by
Valente et al. [8].
Northern Blots
Total RNA was isolated from FRTL-5 cells by the method of Chirgwin et al. [18]
and 30 ,ug electrophoresed in 0.9 percent agarose gels containing formaldehyde, as
described by Maniatis et al. [19]. Following Northern transfer to nitrocellulose
membrane, ODC mRNA was identified, using radiolabeled mouse ornithine decarbox-
ylase cDNA (pOD48) kindly supplied by Dr. P. Coffino, University ofCalifornia, San
Francisco. The 1.6 kilobase insert [17] was purified by electroelution from agarose gels
and labeled to a specific activity of 10-8-10-9 cpm 32p per ,g DNA by the procedure
described by Feinberg and Vogelstein [20]. Pre-hybridization and hybridization were
performed as described by Shackleford and Varmus [21]. Bound radioactivity on the
blots was detected by autoradiography at -700C, using Kodak X-Omat AR film.
RESULTS
The effects ofTSH and serum on ODC activity in FRTL-5 cells are shown in Table
1. Cultures were incubated for six hours in the conditions as noted. Results are
expressed as dpm '4CO2 released from 50 uL cell lysate. The assay blank which
contained all the components of the assay mixture except protein gave a reading of
33 ± 1. Cells incubated in 5H alone showed no increased activity over the assay control
blank. Bovinecalfserum, itselfa modest growth factor in the FRTL-5 cells [14], failed
to stimulate ODC at 5 percent concentration and showed only a small increase at 30
percent concentration. In the absence ofserum, using a wide range ofTSH concentra-
tions and incubation times, stimulation ofODC activity was poor. With TSH, however,
calf serum acted synergistically to induce ODC activity in the FRTL-5 cells. By
increasing the serum concentration from 5 percent to 30 percent, a further increase in
ODC activity was seen in cells incubated for six hours in 1 mU per mL TSH.
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TABLE I
Synergism between Serum and TSH on Ornithine Decarboxylase
Activity in FRTL-5 Cells
dpm CO2 Released
(-) CS (+) 5% CS (+) 30% CS
5H 35+0 34+2 53+ 10
5H + TSH 74 + 6 203 + 66 364 + 10
Assay blank = 33 ± 2. Mean ± SD n = 4
Cells were taken out ofbovinecalfserum for three hours before the
start of the experiment. Incubations in the conditions as noted were
continued for six hours before lysis of the cells and determination of
ODC activity.
Maximal ODC activity required the presence ofthe phosphodiesterase inhibitor, 0.5
mM methyl isobutyl xanthine (MIX). Cells treated with TSH and 0.5 mM MIX for
six hours had almost three times the ODC activity ofcells incubated in TSH alone, as
shown in Fig. 1. Cells incubated in 5H + 5 percent bovine calf serum showed no
significant increase in activity over assay background activity of48 ± 6.
A 24-hour time course of ODC induction following the addition of TSH and 30
percent bovine calfserum isshown in Fig. 2. A biphasic curve with peaks at four and 12
hours was seen, using the optimal conditions for ODC activity determined above.
Experiments examining the time course of enzyme activity over shorter incubation
periods showed nodetectable enzyme activity before four hours and optimal activity at
five to six hours. Experiments examining ODC activity induced by TSH or MIX
independently in the presence ofSH and 30 percent bovine calfserum also showed this
biphasic curve of induction ofODC activity.
The time course of induction ofODC mRNA is shown in Fig. 3. At the start of the
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FIG. 2. Time course of ODC induction following TSH and MIX addition in the
presence of30 percent calf serum. Cells were assayed for ODC activity as described in
the methods at the time noted after addition of I mU/ml TSH and 0.5 mM MIX.
control lane. One hour following media change to TSH, serum, MIX, and 5H, ODC
mRNA was detectable. The level remained high at two hours but started to fall from
this point onward. Detectable levels of ODC mRNA were, however, present at six
hours following TSH and MIX addition.
The effect of TPA and TSH on [methyl-3H]thymidine incorporation is shown in
Table 2. In the absence ofTSH, TPA (10-7M) caused a tenfold increase in thymidine
incorporation. This increase in DNA synthesis was not altered significantly by the
addition of TSH. In the absence of TPA, TSH caused a dose-dependent increase in
[methyl-3H]thymidine incorporation with a 14-fold increase at a concentration of 1
mU per ml. The addition ofTPA did not significantly inhibit the stimulation of DNA
synthesis by TSH. Thus both TSH and TPA appear to increase thymidine incorpora-
tion but do not act in an additive or inhibitory manner in combination. -3
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FIG. 3. Time course ofODC mRNA
induction by 1 mU per mL TSH, 0.5
mM MIX, and 5 percent bovine calf
serum in FRTL-5 cells. Equal amounts
oftotal RNA Wfere loaded per well, and,
following electrophoresis, transferred




Effect of TPA on [Methyl3H]Thymidine Incorporation in the
Presence of TSH in FRTL-5 Cells
dpm x 10'5 ± S.E.M.
[TSH] per mL -TPA +TPA
0 0.23 ± 0.01 2.40 ± 0.56
lOuU 1.11 ± 0.11 2.42 ± 0.38
lOO,U 2.62 ± 0.24 3.16 ± 0.40
1 mU 3.32 ± 0.45 2.70 ± 0.25
Cells were grown as described in Materials and Methods and
assayed for radiolabeled thymidine uptake into acid-precipitable
radioactivity, using the procedure described in Methods.
The effect ofTPA on ODC activity is shown in Fig. 4. TPA alone consistently failed
to stimulate ODC activity in the FRTL-5 cells following a six-hour incubation;
however, I0-8M TPA inhibited TSH-induced ODC activity in the cells. TPA caused a
63 percent reduction in ODC activity compared to the cells incubated in TSH alone.
TPA did not alter the time course for maximal enzyme induction by TSH. The
inhibitory effect was demonstrated at all time points examined, up to seven hours.
The effect of difluoromethylornithine (5 mM) and putrescine (10 ,uM) on ODC
activity stimulated by TSH, MIX, and serum is shown in Fig. 5. Incubation in 10 ,uM
putrescine, a concentration ten times that normally contained in this medium,
inhibited ODC activity. Exogenous putrescine has been shown to cause a rapid decline
in ODC activity because of an increased rate of degradation and decreased rate of
synthesis of the enzyme [1,2]. Difluoromethylornithine (DFMO), an enzyme-
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FIG. 4. Effect ofTPA on TSH-induced ODC activity in FRTL-5 cells. I0-8M TPA,
I mU/ml TSH were added to the cells as indicated. ODC activity was determined
after six hours, as described in Methods.
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FIG. 5. Effect of 5 mM DFMO and 10-5M putrescine on ODC activity. Cells were
incubated in putrescine-free medium in SH and dialysed calf serum for seven days
before the start ofthe experiment. DFMOand putrescine were added to the incubation
medium at the same time as 0.5 mM MIX and 1 mU per mL TSH. The experiment
was terminated after six hours.
The effect of 5 mM DFMO and 10 ,uM putrescine on thymidine incorporation in
FRTL-5 cells cultured under a variety of conditions is shown in Table 3. Cells
incubated with TSH and 5 percent calf serum showed a modest stimulation of
thymidine incorporation. This result was not inhibited by 5 mM DFMO when
putrescine was included in the incubation, but incorporation was inhibited in the
absence of putrescine. Stimulation by 5H in the presence of serum was comparable to
TABLE 3
Effect of DFMO and Putrescine on Methyl [3H]Thymidine Incorporation into FRTL-5 Cells
Stimulated with Various Agents
- Putrescine + Putrescine
- DFMO + DFMO dpm x 10-3 - DFMO + DFMO
CS 3.5 ± 0.6 2.2 ± 0.5 0.7 ± 0.2 1.3 ± 0.9
TSH + CS 10.2 ± 1.7 5.1 ± 2.1 3.5 ± 0.7 3.5 ± 1.2
5H + CS 11.8 ± 4.4 7.6 ± 1.8 6.7 ± 4.9 4.0 ± 0.5
5H + CS + MIX 51.5 ± 8.4 24.6 ± 0.9 21.8 ± 11.4 36.3 ± 10.8
5H + CS + TPA 28.0 ± 5.3 9.4 ± 2.5 13.2 ± 2.6 13.9 ± 3.1
Mean±SD n=4
Following a four-day incubation in putrescine-free medium, putrescine (10-i M) and DFMO (5 mM)
were added as noted. Four days later, incubation medium was changed from 6H to 5H medium and
DFMO and putrescine again replaced. Four days after that, cells were incubated in fresh putrescine-free
medium with the additions as noted and I gCi/mL tritiated thymidine. The experiment was terminated
after three days in this medium.
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TABLE 4
Effect of DFMO on Growth Factor-Induced DNA Synthesis
jig DNA
- DFMO + DFMO
5H 3.1 ±0.7 2.7±0.1
5H + TPA (10-7M) 5.8 ± 0.3 2.9 ± 0.2
6H 12.1 ± 0.7 5.7 ± 0.5
6H + TPA 12.3 ± 0.2 6.1 ± 0.8
Mean ± SD n= 3
Cells were incubated in putrescine-free, 5H medium with 5 percent
dialysed calf serum for five days before the start of the experiment,
with one medium change during this period. Cells were incubated in
fresh medium containing 5 percent dialysed calf serum and the
conditions as noted for four days. DFMO was used at a concentration
of 5 mM and TSH at I mU per mL. DNA was assayed using the
diphenylamine colorimetric assay [7].
that of TSH and was inhibited in the presence of DMFO and in the absence of
putrescine. The phosphodiesterase inhibitor, MIX, a strong stimulator of thymidine
incorporation in the presence of5H and 5 percent calfserum [16], also showed reduced
levels of radiolabeled thymidine incorporation when incubated with DFMO in the
absence ofexogenous putrescine. The effects ofTPA were similarly affected.
The effect of DFMO on growth factor-induced DNA synthesis is shown in Table 4.
In these experiments, SH and 5 percent bovine calf serum were included. Growth
stimulation byTPA was inhibited completely by 5 mM DFMO. Growth stimulation by
TSH (6H) and the combination of TPA with TSH was inhibited by 75 percent over
controls.
DISCUSSION
TSH stimulates both growth and intracellular cAMP accumulation in the FRTL-5
cell line [8]. If indeed ODC induction by trophic stimuli is mediated by cAMP,
treatment ofthese cells with thyrotropin should result in a significant increase in ODC
activity. Calf serum has also been shown to stimulate growth in FRTL-5 [14]. In this
study we found that maximum induction ofODC required the presence of both TSH
and calf serum, acting in a synergistic manner; however, cyclic AMP is clearly a
powerful stimulator because addition of a phosphodiesterase inhibitor enhances the
effects ofTSH and serum.
In response to trophic hormone administration, ODC induction is thought to exhibit
a remarkably constant pattern ofexpression [3]. The time course ofinduction that we
have shown in FRTL-5 cells correlates well with findings from the in vitro stimulation
of rat thyroid by TSH [4,22]. ODC activity during the cell cycle is thought to be
precisely regulated and expressed as a biphasic or double peak of activity, in late GI
and G2, respectively. This phenomenon has been demonstrated in various cells in
culture [1,23]. The second increase in ODC activity shown in this report may represent
the onset oflateGI,just prior to DNA synthesis, which begins approximately 16 hours
following TSH stimulation of quiescent FRTL-5 cells. Increased levels of ODC
mRNA were present at least three hours before there was a detectable increase in
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enzyme activity. The delay in appearance of enzyme activity may be due to post-
translational processing ofthe protein.
TPA also stimulated thymidine incorporation in this clonal line but did not stimulate
ODC activity above background at all incubation times. TPA also inhibited the
induction of ODC by TSH and bovine calf serum but did not reduce TSH-induced
thymidine incorporation. These data provide another example of discrepant effects of
growth factors on DNA synthesis and ODC stimulation. The growth stimulatory
effects of TPA may be mediated through a non-cAMP-dependent pathway as
described by Valente et al. [8]. TPA is known to activate protein kinase C, which
may play a fundamental role in regulating cellular proliferation [24,25]. Possibly the
inhibitory effects ofTPA on TSH-induced ODC activity may be due to a reduction in
cAMP produced following TSH action. Recent data show that phorbol ester may
phosphorylate adenylate cyclase [26], and in rat osteoblasts, van Leeuwen et al. [27]
showed that pre-incubation in TPA resulted in a dose-dependent inhibition of
parathyroid hormone-stimulated cyclic AMP production. TPA also reduced forskolin-
stimulated ODC activity in these cells but not PTH-stimulated ODC. In sheep thyroid
cells in culture, we found that incubation in TPA or EGF with TSH reduced the
accumulation of cyclic AMP [28]. In the preliminary studies, however, we have not
been able to show a statistically significant reduction in cyclic AMP production in cells
pre-treated with TPA for six hours or 24 hours (data not shown).
Data using DFMO show that its effects are prevented by addition of exogenous
putrescine to the incubation medium. The experiments also show that both TSH- and
TPA-stimulated growth are inhibited by DFMO. Although inhibition of the enzyme
by DFMO does inhibit TPA-mediated growth, this process may occur because there
are inadequate basal levels ofpolyamines to support growth rather than a requirement
for elevated levels. There may be a minimum requirement for polyamines that does not
require high levels ofinduction ofthe enzyme. Although ODC levels rise in response to
TSH, our data show that protein kinase C activation results in reduced levels of
enzyme activity while growth is stimulated. Further investigation may reveal that the
FRTL-5 is an example of a cell line in which ODC induction is not necessary for
subsequent cell growth.
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